IRadimed Corporation
IRMD
$85.27
$0.520.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 14.81% | 14.43% | 12.91% | 11.73% | 11.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.81% | 14.43% | 12.91% | 11.73% | 11.04% |
| Cost of Revenue | 15.20% | 15.38% | 13.22% | 12.94% | 9.39% |
| Gross Profit | 14.69% | 14.15% | 12.82% | 11.38% | 11.54% |
| SG&A Expenses | 7.68% | 11.47% | 12.04% | 12.73% | 15.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.09% | 12.46% | 11.36% | 12.04% | 11.93% |
| Operating Income | 23.42% | 19.04% | 16.55% | 11.05% | 9.01% |
| Income Before Tax | 20.85% | 16.83% | 13.98% | 10.30% | 10.36% |
| Income Tax Expenses | 26.62% | 16.66% | 14.92% | 8.45% | 10.26% |
| Earnings from Continuing Operations | 19.34% | 16.87% | 13.73% | 10.80% | 10.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.34% | 16.87% | 13.73% | 10.80% | 10.38% |
| EBIT | 23.42% | 19.04% | 16.55% | 11.05% | 9.01% |
| EBITDA | 25.37% | 19.89% | 16.62% | 10.52% | 8.57% |
| EPS Basic | 18.81% | 16.39% | 13.25% | 10.27% | 9.83% |
| Normalized Basic EPS | 19.49% | 15.50% | 13.45% | 9.73% | 9.76% |
| EPS Diluted | 18.23% | 16.63% | 13.13% | 10.85% | 9.82% |
| Normalized Diluted EPS | 19.40% | 15.31% | 13.26% | 9.68% | 9.83% |
| Average Basic Shares Outstanding | 0.44% | 0.41% | 0.43% | 0.46% | 0.50% |
| Average Diluted Shares Outstanding | 0.52% | 0.59% | 0.60% | 0.52% | 0.44% |
| Dividend Per Share | 15.63% | 51.06% | 51.11% | 120.00% | 326.67% |
| Payout Ratio | 0.64% | -0.06% | -0.37% | -0.26% | -0.11% |